Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
V. Gallo (Rivoli, TO, Italy). A totally Positron Emission Tomography (PET) negative lung cancer. 4279

Member's Comments

No comment yet.

Related content which might interest you: Management of ocular tuberculosis(OTB): The role of CT and Positron Emission Tomography(PET) imaging Source: Virtual Congress 2021 – Challenges and advances in the diagnosis and clinical management of tuberculosis Year: 2021 Positron emission tomography (PET) and computed tomography (CT) in the assessment of the mediastinum for patients with presumed or established lung cancer Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs Year: 2008 Incidental findings in Positron Emission Tomography - Computed Tomography for Lung Cancer Assessment Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment Year: 2018 Positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) for evaluation of indeterminate adrenal mass in patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 596s Year: 2002 Positron emission tomography in sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 212s Year: 2005 Positron emission tomography (PET) using 18F-fluorodeoxyglucose (18FDG) can detect radiographically ”occult“ lung cancer (ROLC) in the central airways Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001 Integrated positron emission tomography-computed tomography (PET-CT) in the staging of lung cancer Source: Annual Congress 2008 - New imaging modalities in the staging of lung cancer Year: 2008 Positron emission tomography findings in round atelectasis Source: Annual Congress 2009 - Old and new: technique and pathology Year: 2009 Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration Source: Eur Respir J 2009; 33: 201-212 Year: 2009 Positron emission tomography in the diagnostic work-up of screening-detected lung nodules Source: Eur Respir J 2015; 45: 501-510 Year: 2015 The place of non-invasive techniques (CT - PET - CT) Source: Annual Congress 2007 - Mediastinal staging for NSCLC Year: 2007 (18)F-FDG positron emission tomography/computed tomography and pulmonary function in sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Fluorodeoxyglucose positron emission tomography (FDG-PET) for detection and staging of bronchioloalveolar carcinoma Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001 Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 227s Year: 2001 Prognostic value of fluorine-18 fluorodeoxyglucose (18-FDG) positron emission tomography imaging in patients with non-small cell lung carcinoma Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Imaging can replace mediastinoscopy: PRO Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005 Imaging the inflammatory activity of sarcoidosis Source: Eur Respir J 2013; 41: 743-751 Year: 2013 Imaging of malignant pleural mesothelioma with fluordeoxyglucose positron emission tomography (FDG-PET) Source: Eur Respir J 2001; 18: Suppl. 33, 396s Year: 2001 Rebuttal Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005